These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 39408277)

  • 1. The Epidemiology and Clinical Management of Short Bowel Syndrome and Chronic Intestinal Failure in Crohn's Disease in Italy: An IG-IBD Survey.
    Pessarelli T; Topa M; Sorge A; Nandi N; Pugliese D; Macaluso FS; Orlando A; Saibeni S; Costantino A; Stalla F; Zadro V; Scaramella L; Vecchi M; Caprioli F; Elli L
    Nutrients; 2024 Sep; 16(19):. PubMed ID: 39408277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic intestinal failure and short bowel syndrome in Crohn's disease.
    Aksan A; Farrag K; Blumenstein I; Schröder O; Dignass AU; Stein J
    World J Gastroenterol; 2021 Jun; 27(24):3440-3465. PubMed ID: 34239262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term clinical evaluation of teduglutide for patients with Crohn's disease on home parenteral support for postoperative short bowel syndrome with intestinal failure.
    Sato T; Uchino M; Takeuchi J; Fujihira Y; Shimizu K; Yokoyama K; Yagi S; Kaku K; Takashima Y; Ikenouchi M; Kojima K; Kawai M; Nagase K; Kamikozuru K; Yokoyama Y; Takagawa T; Ikeuchi H; Watanabe K; Shinzaki S
    Clin Nutr; 2023 May; 42(5):722-731. PubMed ID: 37001195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal iatrogenic hyperadaptation in patients with short bowel syndrome and Crohn's disease: Is this an indication for mandatory lifelong injections of teduglutide?
    Mazzuoli S; Regano N; Lamacchia S; Silvestri A; Guglielmi FW
    Nutrition; 2021; 91-92():111396. PubMed ID: 34399400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crohn's disease patients with chronic intestinal failure receiving long-term parenteral nutrition: a cross-national adult study.
    Elriz K; Palascak-Juif V; Joly F; Seguy D; Beau P; Chambrier C; Boncompain M; Fontaine E; Laharie D; Savoye G; Lerebours E
    Aliment Pharmacol Ther; 2011 Oct; 34(8):931-40. PubMed ID: 21848855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.
    Kochar B; Long MD; Shelton E; Young L; Farraye FA; Yajnik V; Herfarth H
    J Clin Gastroenterol; 2017 Jul; 51(6):508-511. PubMed ID: 27433811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging as predictor of clinical response to teduglutide in adult patients with short bowel syndrome with chronic intestinal failure.
    Martin A; Boehm V; Zappa M; Billiauws L; Bonvalet F; Nuzzo A; Vilgrain V; Joly F; Ronot M
    Am J Clin Nutr; 2021 May; 113(5):1343-1350. PubMed ID: 33675349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment With Biologic Agents Has Not Reduced Surgeries Among Patients With Crohn's Disease With Short Bowel Syndrome.
    Limketkai BN; Parian AM; Chen PH; Colombel JF
    Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1908-1914.e2. PubMed ID: 28666947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors for short bowel syndrome in Crohn's disease.
    Vaillant S; Guillo L; Michot N; D'Amico F; Germain A; Danese S; Baumann C; Rousseau H; Quilliot D; Peyrin-Biroulet L
    Dig Liver Dis; 2020 Dec; 52(12):1455-1460. PubMed ID: 32938546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-Bowel Adaptation: A Case of Morphological Changes Induced by Teduglutide in Short-Bowel Syndrome With Intestinal Failure.
    Mouillot T; Boehm V; Treton X; Ferrandi E; Kapel N; Cazals-Hatem D; Joly F
    JPEN J Parenter Enteral Nutr; 2020 Jul; 44(5):940-943. PubMed ID: 32187383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide-2 analogues for Crohn's disease patients with short bowel syndrome and intestinal failure.
    Pizzoferrato M; Puca P; Ennas S; Cammarota G; Guidi L
    World J Gastroenterol; 2022 Nov; 28(44):6258-6270. PubMed ID: 36504557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory Bowel Disease and Short Bowel Syndrome.
    Fuglestad MA; Thompson JS
    Surg Clin North Am; 2019 Dec; 99(6):1209-1221. PubMed ID: 31676059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Short Bowel Syndrome (SBS) and Intestinal Failure.
    Radetic M; Kamel A; Lahey M; Brown M; Sharma A
    Dig Dis Sci; 2023 Jan; 68(1):29-37. PubMed ID: 36434372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: An international multicenter survey.
    Pironi L; Steiger E; Joly F; Jeppesen PB; Wanten G; Sasdelli AS; Chambrier C; Aimasso U; Mundi MS; Szczepanek K; Jukes A; Theilla M; Kunecki M; Daniels J; Serlie M; Poullenot F; Cooper SC; Rasmussen HH; Compher C; Seguy D; Crivelli A; Santarpia L; Guglielmi FW; Kozjek NR; Schneider SM; Ellegard L; Thibault R; Matras P; Matysiak K; Van Gossum A; Forbes A; Wyer N; Taus M; Virgili NM; O'Callaghan M; Chapman B; Osland E; Cuerda C; Udvarhelyi G; Jones L; Won Lee AD; Masconale L; Orlandoni P; Spaggiari C; Díez MB; Doitchinova-Simeonova M; Serralde-Zúñiga AE; Olveira G; Krznaric Z; Czako L; Kekstas G; Sanz-Paris A; Jáuregui MEP; Murillo AZ; Schafer E; Arends J; Suárez-Llanos JP; Youssef NN; Brillanti G; Nardi E; Lal S; ;
    Clin Nutr ESPEN; 2021 Oct; 45():433-441. PubMed ID: 34620351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.
    Hashash JG; Elkins J; Lewis JD; Binion DG
    Gastroenterology; 2024 Mar; 166(3):521-532. PubMed ID: 38276922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-Marketing Use of Teduglutide in a Large Cohort of Adults with Short Bowel Syndrome-Associated Chronic Intestinal Failure: Evolution and Outcomes.
    de Dreuille B; Nuzzo A; Bataille J; Mailhat C; Billiauws L; Le Gall M; Joly F
    Nutrients; 2023 May; 15(11):. PubMed ID: 37299413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline Characteristics of Adult Patients Treated and Never Treated with Teduglutide in a Multinational Short Bowel Syndrome and Intestinal Failure Registry.
    Gondolesi GE; Pape UF; Mason JB; Allard JP; Pironi L; Casas MNV; Schwartz LK; Joly F; Gabriel A; Sabrdaran S; Zhang P; Kohl-Sobania M; Huang YW; Jeppesen PB
    Nutrients; 2024 Aug; 16(15):. PubMed ID: 39125394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Outcomes Associated With Teduglutide Use in Patients With Both Short Bowel Syndrome and Crohn's Disease.
    Siu RK; Karime C; Hashash JG; Kinnucan J; Picco MF; Farraye FA
    Crohns Colitis 360; 2024 Jan; 6(1):otae007. PubMed ID: 38352117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-World Treatment Patterns and Healthcare Resource Use for Ulcerative Colitis and Crohn's Disease in Italy.
    Dovizio M; Hartz S; Buzzoni C; Redondo I; Nedeljkovic Protic M; Birra D; Perrone V; Veronesi C; Degli Esposti L; Armuzzi A
    Adv Ther; 2024 Jun; 41(6):2282-2298. PubMed ID: 38619721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
    Jeppesen PB; Pertkiewicz M; Forbes A; Pironi L; Gabe SM; Joly F; Messing B; Loth S; Youssef NN; Heinze H; Berghöfer P
    Clin Nutr; 2013 Oct; 32(5):713-21. PubMed ID: 23587733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.